PAR PHARMACEUTICAL COMPANIES, INC. — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2014)

-$105.5M

Total Assets (FY2014)

$3.0B

Total Equity (FY2014)

$561.1M

Cash Flows from Operating Activities (FY2014)

$144.9M

Source: PAR PHARMACEUTICAL COMPANIES, INC. 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.